Kronmal and colleagues also report on analyses suggesting that the relative risks of non-cardiovascular disease mortality associated with diabetes, particularly with respect to death due to infectious or renal causes, were significantly greater among individuals treated with insulin compared with those receiving oral hypoglycaemic agents alone. This evidence concerns the gene INS and diabetes mellitus.